Auron Therapeutics is a Biotech company based in Newton. It has raised $118M in total funding. Backed by Polaris Partners, DCVC, Mubadala.
Auron Therapeutics funding overview
Auron Therapeutics is a Biotech company based in Newton. Auron Therapeutics has raised $118M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Auron Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Polaris Partners, DCVC, Mubadala. 3 distinct backers are named across the disclosed rounds.
Auron Therapeutics at a glance
Total raised
$118M
Latest round date
February 2025
Industry
Biotech
Headquarters
Newton
Notable investors
Polaris Partners, DCVC, Mubadala
Frequently asked about Auron Therapeutics funding
How much has Auron Therapeutics raised?
Auron Therapeutics has raised $118M in total disclosed funding across the rounds on record.
Who has invested in Auron Therapeutics?
Polaris Partners, DCVC, Mubadala are named among the investors backing Auron Therapeutics.
What was the latest Auron Therapeutics funding round?
No round stage has been disclosed for Auron Therapeutics.
Where is Auron Therapeutics based?
Auron Therapeutics is based in Newton.
What sector does Auron Therapeutics operate in?
Auron Therapeutics is tracked under Biotech from Newton, with $118M in disclosed funding.
When did Auron Therapeutics last raise?
The last disclosed Auron Therapeutics round closed in February 2025.
Round data for Auron Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Newton and backer lists below.
